Perhaps it’s some morning stiffness you first notice, or some swelling in your fingers, wrists or toes. The early symptoms of ...

In patients with RA, BMI affects cardiovascular risk, differing by anti–citrullinated protein antibody (ACPA) status and ...

A major Medicare study shows that while long-term steroid use declines after diagnosis of late-onset rheumatoid arthritis, a ...

The global rheumatoid arthritis drugs market was valued at $57,929 million in 2019, and is projected to reach $62,935 million by 2027, registering a CAGR of 2.8% from 2020 to 2027. Alarming rise in ...

In patients with RA, TNF inhibitor use during the 3 years after being diagnosed with early-stage lung, colorectal, or prostate cancer was not linked to decreased survival.

Discover the early warning signs of psoriatic arthritis that could prevent permanent joint damage, plus expert advice on treatment options and daily management.

Therapy for inflammatory joint diseases, such as rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis, includes various conventional disease-modifying antirheumatic drugs (DMARDs).

Netherlands: A new study published in Clinical Rheumatology has highlighted the risks associated with prolonged ...

Based on clinical trial data, abatacept was not associated with increased malignancy risks in RA or PsA; observational data indicated a higher risk vs other b/tsDMARDs.

Janus kinase (JAK) inhibitors are associated with an increased risk for lung cancer but not overall cancer among older patients in the United States with rheumatoid arthritis (RA), according to study ...

Final results from the RA-BEYOND study show that patients with rheumatoid arthritis can often maintain disease control after tapering baricitinib from 4 mg to 2 mg.

Rheumatoid arthritis (RA) patients face very different risks for cardiovascular disease and events depending on their body ...